ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

OPTI Optibiotix Health Plc

17.50
-0.25 (-1.41%)
09 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25 -1.41% 17.50 17.00 18.00 17.75 17.50 17.75 194,018 13:11:33
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Noncomml Resh Organizations 457k 2.59M 0.0284 6.16 15.96M
Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 17.75p. Over the last year, Optibiotix Health shares have traded in a share price range of 5.75p to 43.50p.

Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £15.96 million. Optibiotix Health has a price to earnings ratio (PE ratio) of 6.16.

Optibiotix Health Share Discussion Threads

Showing 37676 to 37700 of 147575 messages
Chat Pages: Latest  1511  1510  1509  1508  1507  1506  1505  1504  1503  1502  1501  1500  Older
DateSubjectAuthorDiscuss
22/5/2018
08:48
You sound like a trader in a hurry!
slartybartfaster
22/5/2018
08:40
Sometimes I despair about the stock market.....especially AIM. some of these companies just never reach the value they deserve. As always I guess patience is a virtue....
nobbygnome
22/5/2018
08:38
Let's hope it's both bob
manc10
22/5/2018
08:31
Most likely J&J imo.
bobalot
22/5/2018
08:29
Remember sbtx came out with a statement ssying a big player has took some of there products for testing could it be seed
manc10
22/5/2018
08:28
Article about Seed, which looks to be written in the future.
loungeact
22/5/2018
08:28
Some sell the price and ignore the business going forward...everyone to their own but it is not where the real money lies...
bobdown2
22/5/2018
08:26
Who is selling a day before the results!?? I'm not sure I can last another 24 hours waiting for a break north... no nails left.
rathean
22/5/2018
08:18
Would imagine seed wouldn't stop at just one of our strains .
Skin has it's biome too

drago
22/5/2018
08:12
It took a very long time for the penny to drop with arm , when the penny drops or rather evidenced this share will do another 10 bags in rapid order , as for timescale it remains to be seen ...
ramas
22/5/2018
07:55
As I said big things just around the corner:-) but guess we all know that anyway.

Good news just keeps coming...

zebbo
22/5/2018
07:51
"agreement with Seed Health ('SeedTM') to produce, promote, market, and commercialise products containing LP-LDL® in the USA."Products (plural). And from recent articles we know we are looking at one for women and one for men as a minimum.
parob
22/5/2018
07:45
Key metrics to look out for tomorrow. Will they mention any of the following? Results are six months out of date, so they need to state:-

1) Cash remaining now. Not end November 2017.

2) Revenues received from December 2017 to end May 2018.

3) Year end predictions for revenues and losses/profits.

Today's RNS is as woolly as ever. No figures mentioned just the usual b*llsh*t about the size of the market which is a total irrelevance e.g. Coffee shop market is massive and worth billions, but try opening a chain now and see how you get on penetrating this billion dollar market!


Results tomorrow and perhaps they'll surprise with figures going forward, but I won't hold my breath.

michaelmouse
22/5/2018
07:09
Lovely. Shame RNS's have to be a bit bland.. would be great to have included Peter Thiel, Cameron Diaz Jessica Beil and Karlie Kloss as backers
trotterstrading
22/5/2018
07:08
We know the product is to launch imminently meaning instant revenues. No wonder SOH has been so confident we will hit break even this year.Get ready for a big publicity and marketing campaign to kick in.High profile backers. Revolutionary science. Ripe market.Seed Health is a game changer.
parob
22/5/2018
07:05
At last the announcement. Now let the publicity begin.
rafboy
22/5/2018
07:02
LP-LDL® agreement for USA



OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces that it has entered into a non-exclusive agreement with Seed Health ('SeedTM') to produce, promote, market, and commercialise products containing LP-LDL® in the USA. OptiBiotix previously announced (RNS: 1 May 2018) that it was in commercial discussions with SeedTM in response to media reports on the launch of its LP-LDL® product in the USA. This announcement confirms the successful conclusion of those discussions.



SeedTM (seed.com) was cofounded and is led by Raja Dhir and Ara Katz to pioneer the application of microbiome science to improve human and planetary health. In collaboration with leading microbiome scientists and a global network of partners and experts in biofermentation, stabilisation and testing, SeedTM state they have developed a new standard for a pipeline of effective, scientifically-validated probiotics that target the human microbiome.



This agreement is a strategic step by OptiBiotix to access the US probiotic supplement market. The US is one of the largest and fastest growing probiotic markets in the world, with supplements alone accounting for $2.06 billion sales, with a projected 55% growth to $3.3 billion by 2021*.



LP-LDL® will be commercialised by SeedTM in an innovative product concept which combines multiple strains of different probiotics which have been selected because of strong clinical trial data. OptiBiotix's LP-LDL® strain has published human data demonstrating statistical and clinical significant reductions in cholesterol and blood pressure, won best scientific abstracts at both ProBiota 2017 and ProBiota 2018, and was finalist as ProBiotic of the year at Vitafoods 2018.



*Market data from 'TRENDS, INNOVATIONS AND OPPORTUNITIES DRIVING THE GLOBAL PROBIOTICS MARKET' (Euromonitor International June 2017).



Stephen O'Hara, CEO of OptiBiotix, commented: "We are pleased to announce this agreement with SeedTM which extends the sale of LP-LDL® into the USA, the world's largest and fastest growing probiotic market. We chose SeedTM due to our shared vision of commercialising products with strong scientific and clinical data, their innovative product concept, and their ability to access the large USA consumer goods market. We are pleased that our strong science, successful human studies and international awards at major scientific conferences has attracted international interest in our products leading to continued regular deal flow as we build multiple revenue streams from partners across the world."

daftbat
22/5/2018
07:02
I'm new to this, are you seeing these buys and sells on level 2?
robo28
21/5/2018
22:44
Suggest you don't watch every trade 🤗🤑🤑🤑big things around the corner
zebbo
21/5/2018
15:53
The market is not a straight bat game it seems. We should be higher today, so frustrating to see.
rafboy
21/5/2018
15:46
Yep there certainly is some lost ground to make up. The 100k plus and 20k plus buys this pm look encouraging...
bobdown2
21/5/2018
14:07
TT, how is it plain for all to see? I'm seeing 100k more buys over sells, yet we are 1p down and one trade cost a premium.
slartybartfaster
21/5/2018
13:43
Rathen the ramper has a lot to learn. No share is a sure fire winner.
monkeywench1
21/5/2018
13:39
May be now we can regain the ground lost earlier.
rafboy
21/5/2018
13:09
MM Games mate, no conspiracy, plain for all to see
trotterstrading
Chat Pages: Latest  1511  1510  1509  1508  1507  1506  1505  1504  1503  1502  1501  1500  Older

Your Recent History

Delayed Upgrade Clock